ArticleJournal for immunotherapy of cancer2022

Small extracellular vesicles induce resistance to anti-GD2 immunotherapy unveiling tipifarnib as an adjunct to neuroblastoma immunotherapy.

Xiaoming Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.